Now

We’re building on decades of global vaccine experience to help protect Australians against certain vaccine-preventable diseases.

MSD is committed to helping protect public health and to the discovery, development and distribution of our vaccines across Australia and around the world. To do so, we are focusing on six key areas:

Global Research and Development

Global Research and Development (R&D)

We invested US$13.5b in R&D across all medicines and vaccines in 2022.¹

Clinical Research

We’re investing in new research technologies involving Australian clinicians, as well as supporting clinical trials and independent clinical research.

Healthcare Professional Education and Awareness

We’re committed to educating healthcare professionals to ensure you are up to date with the latest information on our vaccines.

Supply Chain and Logistics

We have an established network of suppliers for cold chain logistics.

Global Manufacturing

We have consistent and reliable manufacturing capabilities across the world.

Regulatory and Quality

Our experienced team works with Australia’s regulatory authority and Department of Health to help ensure our vaccines reach Australians.

_{References: 1. MSD, Data on file.}

_{AU-NON-00613. Issued November 2023.}